We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Johnson and Johnson | NYSE:JNJ | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.92 | -0.63% | 145.90 | 147.175 | 145.95 | 146.70 | 6,182,984 | 01:00:00 |
FORM 3
| Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
| |
1. Name and Address of Reporting Person * Hait William |
2. Date of Event Requiring Statement (MM/DD/YYYY)
| 3. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [JNJ] |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) See Remarks / | ||
5. If Amendment, Date Original Filed(MM/DD/YYYY) | 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned | |||
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 223158.0000 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Options (Right to Buy) (1) | 2/11/2017 | 2/9/2024 | Common Stock | 59397.0000 | $90.4400 | D | |
Employee Stock Options (Right to Buy) (1) | 2/10/2018 | 2/9/2025 | Common Stock | 51484.0000 | $100.0600 | D | |
Employee Stock Options (Right to Buy) (1) | 2/9/2019 | 2/8/2026 | Common Stock | 54923.0000 | $101.8700 | D | |
Employee Stock Options (Right to Buy) (1) | 2/13/2020 | 2/13/2027 | Common Stock | 41097.0000 | $115.6700 | D | |
Employee Stock Options (Right to Buy) (1) | 2/12/2021 | 2/11/2028 | Common Stock | 37289.0000 | $129.5100 | D | |
Employee Stock Options (Right to Buy) (1) | 2/11/2022 | 2/11/2029 | Common Stock | 37911.0000 | $131.9400 | D | |
Employee Stock Options (Right to Buy) (1) | 2/10/2023 | 2/10/2030 | Common Stock | 49315.0000 | $151.4100 | D | |
Employee Stock Options (Right to Buy) (1) | 2/8/2024 | 2/8/2031 | Common Stock | 33593.0000 | $164.6200 | D | |
Restricted Share Units (2) | 2/8/2024 | (2) | Common Stock | 3059.0000 | (2) | D | |
Restricted Share Units (2) | 2/10/2023 | (2) | Common Stock | 3856.0000 | (2) | D | |
Restricted Share Units (2) | 2/11/2022 | (2) | Common Stock | 7790.0000 | (2) | D |
Remarks: haitpoa1.txt Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Hait William ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933 | See Remarks |
Signatures | ||
Raavi Deol, as attorney-in-fact for William Hait | 1/13/2022 | |
**Signature of Reporting Person | Date |
1 Year Johnson and Johnson Chart |
1 Month Johnson and Johnson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions